COVID-19 vaccines and women's security
Lancet (London, England) - Journal ArticlePandemics such as COVID-19 are gendered with regard to who is infected, who dies, who provides care, who is secured against violence and economic change, and who leads and makes decisions. 1 Vaccines are no different and there is a need to address male bias in vaccine development to make women safe from deadly diseases. 2 For example, clinical trials that are not done in both men and women can raise adverse outcomes during implementation due to sex-based differences in immunological response. 3 The excitement and awe at the speed of COVID-19 vaccine development and delivery needs to be attentive to the social and political dynamics in which the vaccine is delivered—women's work and their security are at the heart of this.
Information
- Volume: 397
- Issue: 10272
- Pages: 357-358
- Date: 2021
- Series title:
- DOI: 10.1016/S0140-6736(20)32727-6